Barbinervic acidCAS# 64199-78-6 |
- Rutundic acid
Catalog No.:BCN5370
CAS No.:20137-37-5
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 64199-78-6 | SDF | Download SDF |
| PubChem ID | 194183 | Appearance | Powder |
| Formula | C30H48O5 | M.Wt | 488.7 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (1R,2R,4aS,6aR,6aS,6bR,8aR,9S,10R,12aR,14bS)-1,10-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | ||
| SMILES | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)O)C)C)C2C1(C)O)C)C(=O)O | ||
| Standard InChIKey | YLHQFGOOMKJFLP-JGLQYCRZSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Barbinervic acid shows anti-bacteria activity (IC50 = 0.098 g x LU(-1), IC50 = 0.27 g x L(-1)) against SA and ESBLs-SA respectively. |
| Targets | Antifection |
Barbinervic acid Dilution Calculator
Barbinervic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.0462 mL | 10.2312 mL | 20.4625 mL | 40.9249 mL | 51.1561 mL |
| 5 mM | 0.4092 mL | 2.0462 mL | 4.0925 mL | 8.185 mL | 10.2312 mL |
| 10 mM | 0.2046 mL | 1.0231 mL | 2.0462 mL | 4.0925 mL | 5.1156 mL |
| 50 mM | 0.0409 mL | 0.2046 mL | 0.4092 mL | 0.8185 mL | 1.0231 mL |
| 100 mM | 0.0205 mL | 0.1023 mL | 0.2046 mL | 0.4092 mL | 0.5116 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Senaetnine
Catalog No.:BCN2127
CAS No.:64191-69-1
- Zanthobungeanine
Catalog No.:BCN6685
CAS No.:64190-94-9
- Z-Hyp-Ome
Catalog No.:BCC3258
CAS No.:64187-48-0
- trans-2,3-Dihydro-3-hydroxyeuparin
Catalog No.:BCN6922
CAS No.:64185-57-5
- 30-Oxolupeol
Catalog No.:BCN6673
CAS No.:64181-07-3
- 5-Acetyl-2-(1-hydroxy-1-methylethyl)benzofuran
Catalog No.:BCN7488
CAS No.:64165-99-7
- Echinoynethiophene A
Catalog No.:BCN4183
CAS No.:64165-98-6
- Nilotinib(AMN-107)
Catalog No.:BCC3643
CAS No.:641571-10-0
- Sedanolide
Catalog No.:BCN8338
CAS No.:6415-59-4
- Longistylin C
Catalog No.:BCN4182
CAS No.:64125-60-6
- Di-O-methylcrenatin
Catalog No.:BCN4608
CAS No.:64121-98-8
- 5-hydroxy-canthin-6-one
Catalog No.:BCN7910
CAS No.:64118-73-6
- Alloimperatorin
Catalog No.:BCC8116
CAS No.:642-05-7
- Akuammigine
Catalog No.:BCN4607
CAS No.:642-17-1
- Alstonine
Catalog No.:BCN4606
CAS No.:642-18-2
- L-Quebrachitol
Catalog No.:BCN2727
CAS No.:642-38-6
- Antiarol
Catalog No.:BCN4185
CAS No.:642-71-7
- CGP 12177 hydrochloride
Catalog No.:BCC6949
CAS No.:64208-32-8
- Thalirugidine
Catalog No.:BCN7706
CAS No.:64215-95-8
- Atracurium oxalate
Catalog No.:BCC8837
CAS No.:64228-78-0
- L189
Catalog No.:BCC7707
CAS No.:64232-83-3
- Taraxasterol acetate
Catalog No.:BCN4184
CAS No.:6426-43-3
- Glutinol acetate
Catalog No.:BCN6675
CAS No.:6426-44-4
- Boc-N-Me-Tyr(Bzl)-OH
Catalog No.:BCC3356
CAS No.:64263-81-6
[Anti-bacteria activity of Puraboeo rutescens and Lysionotus pauciflorus].[Pubmed:22016971]
Zhongguo Zhong Yao Za Zhi. 2011 Jul;36(14):1975-8.
OBJECTIVE: Antibacteria activity of compounds from Puraboeo ruescens and Lysionotus pauciflorus was assayed. METHOD: Disc diffusion was used to isolate compounds in vitro and berberine was positive control. The value of IC50 was assayed by the method of liquid culture. All kinds of chromatography were used to isolate the chemical constituent and structure was identified by MS and NMR spectroscopy. RESULT: Eight compounds were isolated and identified as beta-sitosterol (1), E-3,4-dihydroxy cinnamic acid (2), Barbinervic acid (3), 3beta,19alpha-dihydroxy12-en-28-ursolic acid (4), 28-O-beta-D-glucopyranosyl pomolic acid (5), 5,7-dihydroxy-6,8,4'-trimethoxy flavone (6), 5, 6, 4'-trihydroxy-7,8-dihydroxy flavone (7), 5-hydroxy-6,8,4'-trimethoxy flavone-7-O-beta-D-glucopyranosyl (8). Compound 3, 4 and 6 had activity against SA, MRSA and ESBLs respectively. Compound 3 showed (IC50 = 0.098 g x LU(-1), IC50 = 0.27 g x L(-1)) against SA and ESBLs-SA respectively. Compound 4 (IC50 = 0.130 g x L(-1)) was best to against MR SA. CONCLUSION: Compound 1 - 5 were isolated from this plant for the first time. Compound 7 and 8 was isolated from Gesneriaceae for the first time.
Isolation and absolute stereochemistry of coussaric acid, a new bioactive triterpenoid from the stems of Coussarea brevicaulis.[Pubmed:12946428]
Phytochemistry. 2003 Sep;64(1):293-302.
Coussaric acid (1), a triterpenoid based on an ursane skeleton, and an oleanane-type triterpene acid, 3-epi-spathodic acid (2), as well as four known compounds, Barbinervic acid, scutellaric acid, stigmasterol and stigmasterol glucoside, have been isolated from an EtOAc-soluble extract of the stems of Coussarea brevicaulis. The structures of compounds 1 and 2 were elucidated on the basis of spectroscopic investigation, and single-crystal X-ray crystallography was used to confirm the structure of 1. The absolute stereochemistry of 1 was established by chemical transformations and by the Mosher ester procedure. The potential of the isolates and chemical transformation products to induce quinone reductase was evaluated in mouse Hepa lclc7 hepatoma cells.
